If a COVID-19 vaccine were approved and available for free, 3 in 10 Michiganders would probably take a pass, according to a new survey. That’s a concern for health officials who say Michigan can’t beat the potentially deadly virus until the state develops herd immunity against it.
Residents surveyed who said they will “probably” or “definitely” skip the vaccine are, in large part, worried that it is being developed too quickly.
“As much as I wish the vaccine was the miracle we’re all hoping for, it is being rushed,” said Yvonne Pallone, 40, a behavior analyst in Warren.
In a poll conducted July 25-30 by EPIC-MRA for Bridge Michigan of 600 active and likely voters, a clear majority — 66 percent — said they would likely get the vaccine. Though there were notable partisan differences.
Only about half of those who rated President Trump’s job performance as “excellent” or “good” said they would get the vaccine. By contrast, 77 percent of respondents who were critical of Trump’s job performance indicated they would get the vaccine.
Likewise, among those who approve of Democrat Gov. Gretchen Whitmer’s performance or prefer Democrat presidential candidate Joe Biden, nearly 4 in 5 respondents said they would likely get a vaccine.
Volunteering for a vaccine?
Poll question 1.: If a vaccine is developed that would protect you from the coronavirus and is free to everyone who wants it, would you …?
- 38% - Definitely get it
- 28% - Probably get it
- Probably NOT get it - 12%
- Definitely NOT get it - 18%
- Undecided/Refused - 4%
Poll question 2. For those who indicated they would not get a vaccine: Would you not get a coronavirus vaccine primarily because you …
- Are concerned the vaccine was rushed and not sufficiently tested 49 %
- Do not trust vaccines in general 21%
- Do not think a vaccine for the coronavirus is needed 7%
- Or, because you have other concerns about the vaccine 21%
- Undecided/Refused 2%
For those reluctant to take the COVID-19 vaccine, hesitation crossed political boundaries. Alarm that a vaccine would be rushed too quickly to market during the pandemic troubled a majority of backers of both Trump and Biden who expressed concern about the vaccine.
“It was a rather general response. Just about every demographic group” indicated concern about the speed of vaccine development, said Bernie Porn, president of EPIC-MRA.
The poll had a margin of error of plus or minus 4 percentage points.
Pallone, who has a son, Sebastian, with autism, told Bridge she generally supports vaccines. But she said COVID-19 is simply too new and doctors still don’t know enough about treatments or how the virus affects people long term. It’s also not clear that any immune response triggered by the vaccine would protect against the actual virus, she said.
Yvonne Pallone isn’t against vaccines for herself or her son, Sebastian. But when it comes to a COVID-19 vaccine — “it’s just too fast,” she said. (Courtesy photo)
Pallone said she also worries that a fast-tracked clinical trial would not build a diverse enough participant pool, including those who have underlying health conditions, to know how a vaccine might affect people differently.
Pamela Rockwell, medical director at Ann Arbor-based Domino's Farms Family Medicine, said she’s not surprised there is some hesitation.
- Related: Getting Michiganders to take COVID-19 vaccine: ‘My trust just isn’t there’
- The latest: Michigan coronavirus unemployment, map, curve, updated COVID-19 news
- Dashboard: Michigan coronavirus testing numbers, trends, COVID-19 data
“There’s a natural inclination to be fearful of new things,” said Rockwell, who is a liaison for the American Academy of Family Physicians to the Advisory Committee on Immunization Practices, ACIP, the committee responsible for advising the U.S. Centers for Disease Control and Prevention on vaccines.
There is a global race to develop one or more vaccines to protect people from a novel coronavirus that has already killed more than 700,000 people worldwide and infected more than 18 million. Anthony Fauci, the U.S.’s top infectious disease expert, recently predicted a vaccine likely would be available to the public by early 2021.
Any vaccine, including one being developed by Massachusetts-based Moderna and now under a clinical trial among 30,000 adults in the United States, will undergo rigorous testing, Rockwell said.
“At the first inkling that there’s an adverse safety concern, it will be scrubbed,” she said.
She and other public health experts say containing COVID-19 once and for all rests with achieving “herd immunity” among the general public, meaning enough of a community has become immune to a disease that it makes its spread unlikely to those without immunity.
“If we think about where we are with this pandemic right now, we're making progress, but there's still such a risk out there to COVID. Our way to get around this really is a vaccine,” said Bob Swanson, who leads state immunization efforts for the Michigan Department of Health and Human Services.
It’s unclear what percentage of the population needs to be immune to establish “herd immunity” to COVID-19, he said. Generally, the more contagious the disease, the higher the percentage that’s necessary. It has been estimated that 93 percent to 95 percent of a population needs to be vaccinated to establish herd immunity against measles, for instance. But herd immunity against polio is achieved at a lower percentage, when about 80-86 percent of the population achieves immunity.
“We really need to have buy-in from the public for this vaccine and we need people to want the vaccine so that we can get the population of Michigan protected,” he said.
“If we think about where we are with this pandemic right now, we're making progress, but there's still such a risk out there to COVID. Our way to get around this really is a vaccine,” said Bob Swanson, who leads state immunization efforts for the MDHHS (Photo courtesy of Michigan Department of Health and Human Services)
Swanson, like Rockwell, said he trusts the testing and vetting process behind vaccine development.
But that buy-in may not be easy.
“I’m not in favor of taking risks,” said Patrick Card, 30, a stock clerk and father of two in Temperance in southeast Michigan. Though he said he’s comfortable with long-standing vaccines such as those for measles, COVID-19 is simply too new and understanding of the virus still too thin to rush a vaccine to market.
“I’m not going to be a guinea pig. I wanted [the vaccine] tested first,” he said. “I like the idea of it one day. Right now? It’s too early, and I don’t trust it.”
Still, what is perceived as a rush job may be only part of the concern.
In general, a declining number of Americans say they feel vaccines overall are important, according to a Gallup poll of respondents in December, before news hit of a new coronavirus outbreak. In the poll, 84 percent said they believed it is “extremely” or “very” important that parents vaccinate their children. That’s unchanged in recent years, but down from 94 percent in 2001.
Porn, at EPIC-MRA, said adequate distribution of the vaccine in Michigan will require focused public health messaging that could include testimonials from trusted leaders.
“If they can have that kind of messaging. I think they can get beyond the fear about it being rushed too much,” Porn said.
That’s something that Seabron Bowler, a Detroit police officer, said he wants to hear — reassurance from those he trusts, such as D. Fauci or Dr. Deborah Birx, the White House’s coronavirus task force coordinator.
He said he’ll heed the advice of scientists and doctors long before listening to politicians: “These people — they know what they’re talking about,” he said.